Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Gonda 18 South, 200 First St. SW, Rochester, MN, 55905, USA.
Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Eur Radiol. 2019 Apr;29(4):1684-1692. doi: 10.1007/s00330-018-5755-x. Epub 2018 Oct 4.
The objective of this study was to identify clinical and imaging features that distinguish rheumatoid lung nodules from malignancy.
We conducted a retrospective review of 73 rheumatoid patients with histologically-proven rheumatoid and malignant lung nodules encountered at Mayo Clinic, Rochester, MN (2001-2016). Medical records and imaging were reviewed including a retrospective blinded review of CT and PET/CT studies.
The study cohort had a mean age of 67 ± 11 years (range 45-86) including 44 (60%) women, 82% with a smoking history, 38% with subcutaneous rheumatoid nodules, and 78% with rheumatoid factor seropositivity. Subjects with rheumatoid lung nodules compared to malignancy were younger (59 ± 12 vs 71 ± 9 years, p < 0.001), more likely to manifest subcutaneous rheumatoid nodules (73% vs 20%, p < 0.001) and rheumatoid factor seropositivity (93% vs 68%, p = 0.034) but a history of smoking was common in both groups (p = 0.36). CT features more commonly associated with rheumatoid lung nodules compared to malignancy included multiplicity, smooth border, cavitation, satellite nodules, pleural contact, and a subpleural rind of soft tissue. Optimal sensitivity (77%) and specificity (92%) (AUC 0.85, CI 0.75-0.94) for rheumatoid lung nodule were obtained with ≥ 3 CT findings (≥ 4 nodules, peripheral location, cavitation, satellite nodules, smooth border, and subpleural rind). Key FDG-PET/CT features included low-level metabolism (SUV 2.7 ± 2 vs 7.2 ± 4.8, p = 0.007) and lack of F-fluorodeoxyglucose (FDG)-avid draining lymph nodes.
Rheumatoid lung nodules have distinct CT and PET/CT features compared to malignancy. Patients with rheumatoid lung nodules are younger and more likely to manifest subcutaneous rheumatoid nodules and seropositivity.
• Rheumatoid lung nodules have distinct clinical and imaging features compared to lung malignancy. • CT features of rheumatoid lung nodules include multiplicity, cavitation, satellite nodules, smooth border, peripheral location, and subpleural rind. • Key PET/CT features include low-level metabolism and lack of FDG-avid draining lymph nodes.
本研究旨在确定鉴别类风湿性肺结节与恶性肿瘤的临床和影像学特征。
我们对在明尼苏达州罗彻斯特市梅奥诊所(2001-2016 年)确诊的 73 例经组织学证实的类风湿性和恶性肺结节的类风湿性患者进行了回顾性研究。对病历和影像学资料进行了回顾性分析,包括对 CT 和 PET/CT 研究的回顾性盲法分析。
研究队列的平均年龄为 67±11 岁(45-86 岁),包括 44 名(60%)女性,82%有吸烟史,38%有皮下类风湿结节,78%类风湿因子阳性。与恶性肿瘤相比,类风湿性肺结节患者更年轻(59±12 岁 vs 71±9 岁,p<0.001),更可能出现皮下类风湿结节(73% vs 20%,p<0.001)和类风湿因子阳性(93% vs 68%,p=0.034),但两组均有吸烟史(p=0.36)。与恶性肿瘤相比,更常与类风湿性肺结节相关的 CT 特征包括多发性、光滑边缘、空洞、卫星结节、胸膜接触和胸膜下软组织环。≥3 项 CT 发现(≥4 个结节、外周位置、空洞、卫星结节、光滑边缘和胸膜下软组织环)对类风湿性肺结节具有最佳的敏感性(77%)和特异性(92%)(AUC 0.85,CI 0.75-0.94)。FDG-PET/CT 的关键特征包括低代谢水平(SUV 2.7±2 与 7.2±4.8,p=0.007)和缺乏 F-氟脱氧葡萄糖(FDG)-活性引流淋巴结。
与恶性肿瘤相比,类风湿性肺结节具有独特的 CT 和 PET/CT 特征。类风湿性肺结节患者更年轻,更有可能出现皮下类风湿结节和血清阳性。
与肺癌相比,类风湿性肺结节具有明显的临床和影像学特征。
类风湿性肺结节的 CT 特征包括多发性、空洞、卫星结节、光滑边缘、外周位置和胸膜下软组织环。
PET/CT 的关键特征包括低代谢水平和缺乏 FDG-活性引流淋巴结。